Displaying 131 - 140 of 891 Results
News Human Rights Lawsuits | Sexual Abuse

New Jersey Lookback Window Law Clears The Way For Childhood Sexual Abuse Claims

June 1, 2020 | by: Motley Rice
Recent changes to New Jersey state law in May 2019 that broadened the statute of limitations, or the time in which a person can file a claim, for civil childhood sexual abuse claims are constitutional, Morris County’s Superior Court Judge Paul Bogaard ruled.
News Human Rights Lawsuits | Sexual Abuse

New York extends childhood sexual abuse “lookback window” deadline due to COVID-19

May 15, 2020 | by: Motley Rice
New York extended its deadline to file civil sexual abuse claims under the state’s Child Victims Act to Aug. 14, 2021 due to COVID-19.
News Medical Drugs

Zantac lawsuit update: Medical attorney Carmen Scott appointed to leadership position in national litigation

May 13, 2020 | by: Motley Rice
Litigation concerning claims that the popular antacid medication Zantac causes cancer continues to move forward with U.S. District Judge Robin Rosenberg on May 8, 2020, appointing attorneys to lead the multidistrict litigation, a national consolidation of individual cases.
News Asbestos Exposure | Medical Drugs | Women’s Health Lawsuits

Ovarian cancer claims against J&J can move forward, Court rules

May 1, 2020 | by: Motley Rice
Thousands of women who allege Johnson & Johnson’s talc-based baby powder caused their ovarian cancer can move forward with claims against the company, a federal judge ruled on April 27.
News Medical Drugs

FDA takes action, issues immediate removal request of generic Zantac (ranitidine) medications

April 3, 2020 | by: Motley Rice
Recalls involving the name-brand heartburn drug Zantac (ranitidine) and similar generic versions culminated April 1 in the FDA asking drug manufacturers to immediately withdraw all prescription and over-the-counter ranitidine products, including generic ones, from the U.S. market due to concerns that they may contain…
News Antitrust | Medical Drugs

Loestrin antitrust litigation settlement reached

March 30, 2020 | by: Motley Rice
Motley Rice, as co-lead and trial counsel for end-payor plaintiffs, helped reach a $62.5 million class action settlement to resolve claims alleging pharmaceutical drug manufacturers engaged in anticompetitive conduct to delay market entry of generic Loestrin 24 FE.
News Personal Injury Lawsuits

Replacement Takata airbags recalled

March 6, 2020 | by: Motley Rice
Airbag manufacturer Takata Corp., announced yet another major recall of 10 million potentially defective airbag inflators, the latest in a series that amounted to the largest automotive recall in U.S. history.
News Transportation Accident Lawsuits | Personal Injury Lawsuits

Brothers Injured in Pennsylvania Turnpike Crash File Suit Against Tour Bus Company

March 5, 2020 | by: Motley Rice
Two brothers filed suit today against Z&D Tour, Inc., seeking compensatory and punitive damages related to a Jan. 5, 2020 bus crash on the Pennsylvania Turnpike that severely injured them, along with dozens of other passengers, and claimed five lives.
News Human Rights Lawsuits

JPML Rules That Hilton Sex Trafficking Claims Are Too Unique To Consolidate

February 14, 2020 | by: Motley Rice
The U.S. Judicial Panel on Multidistrict Litigation declined on February 5 to establish a multidistrict litigation (MDL) of consolidated claims for sex trafficking victims against various hotel chains.
News Medical Drugs

Heartburn drug manufacturers recall Zantac (ranitidine) due to “unacceptable levels” of toxic, carcinogen NDMA

February 14, 2020 | by: Motley Rice
The FDA recently announced multiple recalls of heartburn medicine Zantac (ranitidine) tablets that may contain N-Nitrosodimethylamine (NDMA), a substance that the WHO says may cause stomach, bladder, kidney, pancreatic, colon and other cancers in humans.